APS

2025 APS Annual Convention · 2025

Intranasal Oxytocin to Treat Mental Disorders: A Meta-Analysis of Randomized Controlled Trials

Washington, DC · May 2025

Poster · Clinical Science

  • Justin Bonnieux
    Concordia University, Montreal, QC.
  • Kellie-Anne Bélisle
    Concordia University
  • Alexandra Harboun
    Concordia University
  • Alexandra Haddad
    Concordia University
  • Alison McLellan
    Concordia University
  • Leo Chester-Trudel
    Concordia University
  • Olivia Quintus-Bosz
    Concordia University
  • David Garred
    Concordia University
  • Florencia Trespalacios
    Concordia University
  • Tiffany Resendes
    Concordia University
  • Stephanie Gumuchian
    Concordia University
  • Mark Ellenbogen
    Concordia University

Abstract

Intranasal oxytocin has received growing attention for its potential to improve the treatment of mental disorders. The current systematic review is the first to meta-analyze clinical outcomes across psychiatric diagnoses since 2013. Overall efficacy was null; meta-regressions will uncover key individual and contextual factors influencing oxytocin’s effects in clinical populations.

Psychopathology

← Poster Session VIII